Subscribe to RSS



Stocks in Momentum: Ascena Retail Group, Ciena, JDS Uniphase, ADTRAN, Finisar, Exelon, Just

Ascena Retail Group Inc (NASDAQ:ASNA) declared that its fiscal Q3 earnings dropped 37% as the women’s apparel retailer recorded higher expenses and acquisition-related costs, masking revenue growth.

Shares of Ascena Retail Group Inc (NASDAQ:ASNA) opened at $18.05 with 158.66 million outstanding shares and touched its highest price of $18.30 during the day and then finished at $18.13 by scoring -8.71%. In the whole session, it traded on volume of 5.22 million shares which turned higher than its average volume.

Ciena Corporation (NASDAQ:CIEN) reported that its fiscal Q2 loss narrowed as the networking-equipment firm’s revenue topped its own forecast. The firm as well anticipated current-quarter revenue above analysts’ predicted.

Ciena Corporation (NASDAQ:CIEN) stock hit highest price at $19.19, beginning with a price of $18.45 and reported a gain of +17.41% to the closed at $19.15 with a day range of $18.17-$19.19. The total market capitalization remained $1.94 billion, total volume of 24.01 million shares held in the session was surprisingly higher than its average volume of 3.35 million shares.

Fellow suppliers also increased, counting JDS Uniphase Corp (NASDAQ:JDSU), ADTRAN, Inc. (NASDAQ:ADTN), and Finisar Corporation (NASDAQ:FNSR).

JDS Uniphase Corp (NASDAQ:JDSU) begun last trade with a price of $13.70 and throughout the trading session climbed at a high of $14.23. The day-trade ended with an advance of +8.30% to $14.22. The stock is going forward its 52 week low with 67.89% and lagging behind from its 52 week high price with -9.02%. JDSU last month stock price volatility remained 2.61%.

Shares of ADTRAN, Inc. (NASDAQ:ADTN) traded at $23.53 by plunging +5.07% with price volatility of 3.38% for a week and 2.85% for a month. Its price volatility’s Average True Range for 14 days was 0.74 and its beta stands at 1.16 times. The stock after opening at $23.53 hit high price of $24.55 and on last session stock held volume of 918,694 shares which was unexpectedly higher than its average volume of 786,936 shares.

Finisar Corporation (NASDAQ:FNSR) stock hit highest price at $13.95, beginning with a price of $13.50 and reported a gain of +4.89% to the closed at $13.52 with a day range of $13.41-$13.95. The stock is going forward its 52 week low with 23.47% and lagging behind from its 52 week high price with -21.12%.

Exelon Corporation (NYSE:EXC) stock hit highest price at $31.59, beginning with a price of $31.34 and reported a gain of +0.29% to the closed at $31.50 with a day range of $31.25-$31.59. The total market capitalization remained $26.96 billion, total volume of 7.64 million shares held in the session was surprisingly higher than its average volume of 26.96 million shares.

Just Energy Group, Inc. Ordinary Shares (Canada) (NYSE:JE) begun last trade with a price of $6.63 and throughout the trading session climbed at a high of $6.75. The day-trade ended with an advance of +0.45% to $6.68. The stock is going forward its 52 week low with 18.30% and lagging behind from its 52 week high price with -37.06%. JE last month stock price volatility remained 3.74%.


Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here

0 comments

Other articlesgo to homepage

Alibaba BABA Surpases IPO Expectations – Closes at $93.89

Alibaba BABA Surpases IPO Expectations – Closes at $93.89

After months of speculation, numerous financial observations from industry experts, a two week road shoe that included presentations from CEO Jack Ma. Alibaba Group Holding Ltd., China’s e-commerce titan finally IPO’d on Friday and blew away any doubt that this was to be a historic event. The low $60 IPO range was immediately bypassed as

Crown Equity Holdings Released That Board Of Directors Increased From 6 To 8, Milestone Is Hit With Completion Of 1263 Community Website Publications

Crown Equity Holdings Released That Board Of Directors Increased From 6 To 8, Milestone Is Hit With Completion Of 1263 Community Website Publications

The Board of Directors of Crown Equity Holdings Inc. (PINK:CRWE) recently made public the election of Harold Gewerter and Brett Matus as the company’s newest members to its Board of Directors immediately effective. Mr. Gewerter and Mr. Matus’ appointment increases the Board from 6 to 8 directors. Harold Gewerter became the Board’s Chairman and Steven

Crown Equity Holdings Announced Completion Of California Network Community, Reverse Split, And Increase Of Board Directors From 6 To 8

Crown Equity Holdings Announced Completion Of California Network Community, Reverse Split, And Increase Of Board Directors From 6 To 8

Crown Equity Holdings Inc. (PINK: CRWE) recently announced a milestone in completing the entire State of California with its CRWE-PR network platform of community that targets news and information publications sites. The CRWE-PR network (http://crwe-pr.com) has also finished sites for communities that are in the Northern and Southern Nevada, as well as ten provinces in

Uphill Outlook: Steel Dynamics Inc (Nasdaq:STLD), Herman Miller Inc (Nasdaq:MLHR), CLARCOR Inc (NYSE:CLC), United Natural Foods Inc (Nasdaq:UNFI)

Uphill Outlook: Steel Dynamics Inc (Nasdaq:STLD), Herman Miller Inc (Nasdaq:MLHR), CLARCOR Inc (NYSE:CLC), United Natural Foods Inc (Nasdaq:UNFI)

Shares of Steel Dynamics Inc. (Nasdaq:STLD) surged $0.91 (or +3.80%) to $24.85, with a total volume of 5,785,118 shares traded on Wednesday, increased activity versus its average volume (3m) of 3,580,150 The company said that it expects third quarter 2014 earnings in the range of $0.42 to $0.46 per diluted share (excluding estimated charges of

Flexion Therapeutics Inc (Nasdaq:FLXN) and Echo Therapeutics Inc (Nasdaq:ECTE) Shadowed Perspectives, Alibaba Group Holding Ltd (BABA) IPO Take It Or Leave It

Flexion Therapeutics Inc (Nasdaq:FLXN) and Echo Therapeutics Inc (Nasdaq:ECTE) Shadowed Perspectives, Alibaba Group Holding Ltd (BABA) IPO Take It Or Leave It

Shares of Flexion Therapeutics, Inc. (Nasdaq:FLXN) declined slightly $0.23 (or -1.17%) to $19.38, with a total volume of 52,631 shares traded on Wednesday’s market activity. The clinical-stage specialty pharmaceutical company said that the FDA placed a clinical hold on patient enrollment and dosing in an ongoing Phase 2b clinical trial of its osteoarthritis pain treatment

read more

Sign Up*

Receive Our Newsletter!

 



 

 

Contacts and information

Social networks

Most popular categories

© 2014 Crown Equity Holdings Inc. All rights reserved.